102 results
S-3ASR
OCUL
Ocular Therapeutix Inc
25 Mar 24
Automatic shelf registration
4:40pm
of the State of Delaware in 2006. Our principal executive offices and research and development operations are located at 15 Crosby Drive, Bedford, MA
8-K
EX-99.1
OCUL
Ocular Therapeutix Inc
11 Mar 24
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
4:10pm
. Total net revenue for the full year 2023 was $58.4 million versus $51.5 million in 2022, an increase of 13.4%.
Research and development expenses … ,
Revenue:
Product revenue, net
Collaboration revenue
Total revenue, net
Costs and operating expenses:
Cost of product revenue
Research and development
424B5
00ud dbr2i
14 Dec 23
Prospectus supplement for primary offering
4:09pm
424B5
c7lomadpn66he4
13 Dec 23
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
uxncltksfu7bg
7 Nov 23
Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update
4:04pm
8-K
EX-99.1
g5c077kjad0cbsxf
7 Aug 23
Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update
4:06pm
8-K
EX-99.1
y6i30n97wky btoig
8 May 23
Ocular Therapeutix™ Provides First Quarter 2023 Financial Results and Corporate Update
4:04pm
8-K
EX-99.1
v6r 7i2rmdyz7zp4
7 Nov 22
Ocular Therapeutix™ Reports Third Quarter 2022 Financial Results and Business Update
4:04pm